New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
NeuroPace, Inc.
NPCE
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

176M

Medical - Devices

Next Earning date - 12 Nov 2024

176M

Medical - Devices

Next Earning date - 12 Nov 2024

6.02USD
Shape-0.02 ( -0.32%)
Market Open
favorite-chart

Relative Strenght

92
favorite-chart

Volume Buzz

-94%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

67%

Quote Panel

Shape
Updated October 25, 2024
1W -2.89 % 1M -10.40 % 3M -24.36 % 1Y -3.36 %

Key Metrics

Shape
  • Market Cap

    175.79M


  • Shares Outstanding

    29.20M


  • Share in Float

    14.66M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    6.0209


  • Average Volume

    55662


  • Beta

    1.785


  • Range

    5.66-18.15


  • Industry

    Medical - Devices


  • Website

    https://www.neuropace.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.46x

P/S Ratio

17.63x

P/B Ratio

6.1

Debt/Equity

-41.6%

Net Margin

$-1.1

EPS

How NPCE compares to sector?

P/E Ratio

Relative Strength

Shape

NPCE

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$89M

Shape361%

2025-Revenue

$1.01

Shape-290%

2025-EPS

$49M

Shape-738%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wells Fargo

upgrade

Previous: Buy

2024-03-14

Now: Overweight

Piper Sandler

initialise

Previous: Not converted

2023-02-22

Now: Neutral

Cowen & Co.

initialise

Previous: Not converted

2023-02-22

Now: Neutral

Lake Street

initialise

Previous: Not converted

2023-02-22

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.48
vs -0.34

Q4.22

arrow
arrow

N/A

-0.45
vs -0.44

Q1.23

arrow
arrow

N/A

-0.41
vs -0.47

Q2.23

arrow
arrow

N/A

-0.36
vs -0.52

Q3.23

arrow
arrow

N/A

-0.28
vs -0.48

Q4.23

arrow
arrow

N/A

-0.23
vs -0.45

Q1.24

arrow
arrow

N/A

-0.32
vs -0.41

Q2.24

arrow
arrow

N/A

-0.26
vs -0.36

Q3.24

arrow
arrow

N/A

-0.27
vs -0.28

Q4.24

arrow
arrow

N/A

-0.25
vs -0.23

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+8%

11.2M  vs 10.3M

Q4.22

arrow
arrow

+16%

12.8M  vs 11M

Q1.23

arrow
arrow

+27%

14.5M  vs 11.4M

Q2.23

arrow
arrow

+62%

16.5M  vs 10.2M

Q3.23

arrow
arrow

+47%

16.4M  vs 11.2M

Q4.23

arrow
arrow

+41%

18M  vs 12.8M

Q1.24

arrow
arrow

+25%

18.1M  vs 14.5M

Q2.24

arrow
arrow

+17%

19.3M  vs 16.5M

Q3.24

arrow
arrow

+16%

19.1M  vs 16.4M

Q4.24

arrow
arrow

+15%

20.7M  vs 18M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-31%

-0.31
vs -0.27

Q4.22

arrow
arrow

-36%

-0.36
vs -0.31

Q1.23

arrow
arrow

-52%

-0.52
vs -0.36

Q2.23

arrow
arrow

-43%

-0.43
vs -0.52

Q3.23

arrow
arrow

-44%

-0.44
vs -0.43

Q4.23

arrow
arrow

-30%

-0.30
vs -0.44

Q1.24

arrow
arrow

-62%

-0.62
vs -0.30

Q2.24

arrow
arrow

-76%

-0.76
vs -0.62

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

27

27
vs 27

NA

Q4.22

arrow
arrow

22

22
vs 27

-19%

Q1.23

arrow
arrow

24

24
vs 22

9%

Q2.23

arrow
arrow

22

22
vs 24

-8%

Q3.23

arrow
arrow

24

24
vs 22

9%

Q4.23

arrow
arrow

41

41
vs 24

71%

Q1.24

arrow
arrow

58

58
vs 41

41%

Q2.24

arrow
arrow

54

54
vs 58

-7%

Earnings Growth

Latest News